The global active humidifier devices market, a vital component of respiratory care, is set to experience a modest decline over the next decade. Valued at USD 1,264.4 million in 2023, the market is expected to see a slight decrease to USD 1,206.9 million by 2033, reflecting a negative compound annual growth rate (CAGR) of -0.5%.
The active humidifier devices market saw tremendous growth during the COVID-19 pandemic, with an impressive CAGR of 28.7%. These devices played a critical role in respiratory support, particularly for patients on mechanical ventilation, where humidified air improved respiratory outcomes. In response to the pandemic-driven demand, manufacturers rapidly introduced a range of innovative active humidifiers, which proved lifesaving for countless patients.
However, as global health systems stabilize post-pandemic, the need for these devices has tapered, leading to a gradual decline in market growth. In addition to reduced demand, the industry faces challenges surrounding the safety of active humidifiers, particularly issues like water buildup in tubing circuits and infection risks. These concerns have spurred a wave of industry innovation, with manufacturers focusing on developing safer and more efficient alternatives to address these safety considerations.
Despite the current contraction, industry experts remain optimistic about the long-term outlook of the active humidifier devices market. As manufacturers continue to advance respiratory care technology, the market is poised for potential recovery driven by next-generation solutions that enhance patient safety and care.
Regional Insights
- North America is set to maintain a leading position, with an estimated market share of over 29.4% in 2023. The United States alone is projected to capture a significant share of above 27.8%.
- Europe follows, with an anticipated value share of over 12.2% in 2023. Germany, in particular, holds a notable 4% share of the global market.
- Japan is expected to contribute a value share exceeding 9.7%.
- Conversely, Australia and India are projected to experience negative growth rates of -1.3% and -2.8%, respectively.
- China is expected to exhibit a modest CAGR of 1.5% from 2023 to 2033.
- The United Kingdom is anticipated to see a minimal growth rate of 0.1% CAGR.
Product and Application Insights
- Electronic humidifiers are expected to dominate, holding a projected value share of 55.79%.
- Adults are the primary users, accounting for 87.99% of the market.
- The invasive ventilation segment is a major contributor, representing 47% of market growth.
- Hospitals are the largest end-users, forming 64.5% of the market share.
Heightened Market Interest: Our Complete Report Delivers Extensive Analysis and Trends!
Historical Developments and Long-term Strategies
Active humidifier device manufacturers have faced a decline from the historical high growth driven by COVID-19. For instance, Hamilton Medical’s introduction of the H900 active humidifier in 2016 marked a significant advancement in the industry.
To navigate current challenges, key players are focusing on strategic collaborations, partnerships, and acquisitions. Recent notable developments include:
- Vadi Medical Technology’s expansion of its product line with the VH3000-220 Humidifier in January 2021.
- Intersurgical Ltd.’s establishment of a new office in Canada to enhance product availability.
- WILAmed GmbH’s launch of the AIRcon Gen2 Respiratory Humidifier in 2019.
Market Dominance by Key Players in the Market:
- Fisher & Paykel Healthcare Limited
- Koninklijke Philips N.V.(Philips Respironics)
- Vapotherm
- Teleflex Corporation
- ResMed Corporation
- VINCENT MEDICAL HOLDINGS LIMITED
- Armstrong Medical (an Eakin Company)
- Breas Medical AB (Subsidiary of Fosun Pharma)
- BMC Medical Co., Ltd
- Hamilton Medical AG
- SunMed
- WILAmed GmbH
- Flexicare (Group) Limited
- Penlon Limited
- DEAS S.R.L.
- Intersurgical Ltd
- Beijing Aeonmed Co., Ltd.
- Shenyang RMS MEDICAL TECH CO., LTD
- GaleMed Corporation
- Vadi Medical Technology Co, Ltd.
Active Humidifier Devices by Category:
Product Type:
- Heated/electronic Humidifiers
- Bubble Humidifiers
- Accessories
Age Group:
- Adult
- Pediatric
- Neonates
Application:
- Invasive Ventilation
- Non-invasive Ventilation
- nCPAP (Nasal Continuous Positive Airway Pressure)
- Bubble CPAP (Bubble Continuous Positive Airway Pressure)
- High Flow Oxygen Therapy
End User:
- Hospitals
- Less than 100 Beds
- 100-300 Beds
- 300-500 Beds
- 500 Beds and More
- Ambulatory Surgical Centers
- Sleep Centers
Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- The Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
